One of the primary drivers of the electronic aspirin market is the increasing prevalence of chronic headache and migraines worldwide. According to the World Health Organization, headaches are one of the most common health conditions worldwide, affecting more than 50% of the adult population. Migraines are also a prevalent condition, affecting an estimated 1 in 7 people globally. As the prevalence of these conditions continues to rise, the demand for effective and safe treatment options is also increasing.
Another significant driver of the electronic aspirin market is the growing concern over the long-term use of traditional medication for chronic headaches and migraines. Traditional medication for chronic headaches and migraines often involves the use of non-steroidal anti-inflammatory drugs (NSAIDs) or opioids. These medications can have unwanted side effects, such as gastrointestinal bleeding, liver damage, and addiction. As a result, many patients are seeking alternative treatment options that do not involve medication.
Read More:
https://knackersblogger.blogspot.com/2023/03/the-global-electronic-aspirin-market-is.html
